| [1] |
Yang JD, Roberts LR. Epidemiology and management of hepatocellular carcinoma[J]. Infect Dis Clin North Am, 2010, 24(4): 899-891, viii.
|
| [2] |
Lai EC, Lau WY. The continuing challenge of hepatic cancer in Asia[J]. Surgeon, 2005, 3(3):210-215.
|
| [3] |
Lau WY, Lai EC. Hepatocellular carcinoma: current management and recent advances[J]. Hepatobiliary Pancreat Dis Int, 2008, 7(3): 237-257.
|
| [4] |
Lau WY, Yu SC, Lai EC, et al. Transarterial chemoembolization for hepatocellular carcinoma[J]. J Am Coll Surg, 2006, 202(1):155-168.
|
| [5] |
Lammer J, Malagari K, Vogl T, et al. Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study[J]. Cardiovasc Intervent Radiol, 2010, 33(1):41-52.
|
| [6] |
Golfieri R, Giampalma E, Renzulli M, et al. Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma[J]. Br J Cancer, 2014, 111(2):255-264.
|
| [7] |
Lau WY, Lai EC, Leung TW. Current role of selective internal irradiation with yttrium-90 microspheres in the management of hepatocellular carcinoma: a systematic review[J]. Int J Radiat Oncol Biol Phys, 2011, 81(2):460-467.
|
| [8] |
Salem R, Lewandowski RJ, Mulcahy MF, et al. Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres:a comprehensive report of long-term outcomes[J]. Gastroenterology, 2010, 138(1):52-64.
|
| [9] |
Lobo L, Yakoub D, Picado O, et al. Unresectable hepatocellular carcinoma: radioembolization versus chemoembolization:a systematic review and meta-analysis[J]. Cardiovasc Intervent Radiol, 2016, 39(11):1580-1588.
|
| [10] |
Lau WY, Lai EC. The current role of radiofrequency ablation in the management of hepatocellular carcinoma: a systematic review[J]. Ann Surg, 2009, 249(1):20-25.
|
| [11] |
Orlando A, Leandro G, Olivo M, et al. Radiofrequency thermal ablation vs. percutaneous ethanol injection for small hepatocellular carcinoma in cirrhosis: meta-analysis of randomized controlled trials[J]. Am J Gastroenterol, 2009, 104(2):514-524.
|
| [12] |
Vietti Violi N, Duran R, Guiu B, et al. Efficacy of microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma in patients with chronic liver disease: a randomised controlled phase 2 trial[J]. Lancet Gastroenterol Hepatol, 2018, 3(5): 317-325.
|
| [13] |
Facciorusso A, Di Maso M, Muscatiello N. Microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma: a systematic review and meta-analysis[J]. Int J Hyperthermia, 2016, 32(3):339-344.
|
| [14] |
Chen MS, Li JQ, Zheng Y, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma[J]. Ann Surg, 2006, 243(3):321-328.
|
| [15] |
Huang J, Yan L, Cheng Z, et al. A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria[J]. Ann Surg, 2010, 252(6):903-912.
|
| [16] |
Feng K, Yan J, Li X, et al. A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma[J]. J Hepatol, 2012, 57(4):794-802.
|
| [17] |
吕明德，匡铭，梁力建，等．手术切除和经皮热消融治疗早期肝癌的随机对照临床研究[J]．中华医学杂志，2006, 86(12):801-805.
|
| [18] |
Fang Y, Chen W, Liang X, et al. Comparison of long-term effectiveness and complications of radiofrequency ablation with hepatectomy for small hepatocellular carcinoma[J]. J Gastroenterol Hepatol, 2014, 29(1):193-200.
|
| [19] |
Ng KKC, Chok KSH, Chan ACY, et al. Randomized clinical trial of hepatic resection versus radiofrequency ablation for early-stage hepatocellular carcinoma[J]. Br J Surg, 2017, 104(13):1775-1784.
|
| [20] |
Shiina S, Tateishi R, Arano T, et al. Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors[J]. Am J Gastroenterol, 2012, 107(4):569-577.
|
| [21] |
N'Kontchou G, Mahamoudi A, Aout M, et al. Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis[J]. Hepatology, 2009, 50(5):1475-1483.
|
| [22] |
Kim YS, Lim HK, Rhim H, et al. Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors[J]. J Hepatol, 2013, 58(1): 89-97.
|